Metabolic control of rat heart glycolysis after acute ischaemia. Fluoracetate treatment and thyroid interactions.
D000244:Adenosine Diphosphate / Q000032:analysis; D000249:Adenosine Monophosphate / Q000032:analysis; D000255:Adenosine Triphosphate / Q000032:analysis; D000818:Animals; D005463:Fluoroacetates / Q000494:pharmacology*; D005636:Fructosephosphates / Q000032:analysis; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D005958:Glucosephosphates / Q000032:analysis; D005985:Glyceraldehyde / Q000032:analysis; D005993:Glycerolphosphate Dehydrogenase / Q000032:analysis; D005994:Glycerophosphates / Q000032:analysis; D006019:Glycolysis / Q000187:drug effects; D006593:Hexokinase / Q000032:analysis; D007037:Hypothyroidism / Q000503:physiopathology; D000860:Hypoxia / Q000378:metabolism; D007511:Ischemia / Q000378:metabolism*; D008297:Male; D009203:Myocardial Infarction / Q000378:metabolism / Q000503:physiopathology; D009206:Myocardium / Q000032:analysis / Q000201:enzymology / Q000378:metabolism*; D010710:Phosphates / Q000032:analysis; D010732:Phosphofructokinase-1 / Q000032:analysis; D010734:Phosphogluconate Dehydrogenase / Q000032:analysis; D011770:Pyruvate Kinase / Q000032:analysis; D011773:Pyruvates / Q000032:analysis; D051381:Rats; D013961:Thyroid Gland / Q000502:physiology*; D013963:Thyroid Hormones / Q000494:pharmacology / Q000502:physiology
D005463:Fluoroacetates; D005636:Fructosephosphates; D005958:Glucosephosphates; D005994:Glycerophosphates; D010710:Phosphates; D011773:Pyruvates; D013963:Thyroid Hormones; D005985:Glyceraldehyde; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D005993:Glycerolphosphate Dehydrogenase; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D006593:Hexokinase; D010732:Phosphofructokinase-1; D011770:Pyruvate Kinase